Arvinas Strengthens Board Commitment with Major Equity Package to Director Bain

Rhea-AI Filing Summary

Director Linda Bain of Arvinas received significant equity compensation on June 25, 2025, consisting of two components:

• 16,025 Restricted Stock Units (RSUs) granted at $0, increasing her direct common stock ownership to 26,045 shares
• 23,105 Stock Options with an exercise price of $7.80 per share, expiring June 24, 2035

Both the RSUs and stock options will vest in full on the earlier of June 25, 2026 or the first board meeting following the next annual stockholder meeting, contingent on continued service. This equity grant appears to be part of the company's director compensation program, aligning the director's interests with shareholders through a combination of full-value shares and performance incentives.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Bain Linda

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	23,105	$0.00	--
Grant/Award	Common Stock	16,025	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 23,105 shares (Direct); Common Stock — 26,045 shares (Direct)

Footnotes (1)

1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bain Linda

(Last) (First) (Middle)

C/O ARVINAS, INC.

5 SCIENCE PARK, 395 WINCHESTER AVE.

(Street)

NEW HAVEN CT 06511

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARVINAS, INC. [ ARVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/25/2025		A		16,025(1)	A	$0	26,045	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$7.8	06/25/2025		A		23,105		(2)	06/24/2035	Common Stock	23,105	$0	23,105	D

Explanation of Responses:

1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

2. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

Remarks:

	/s/ Jared Freedberg, as attorney-in-fact for Linda Bain	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock awards did Linda Bain receive from ARVN on June 25, 2025?

Linda Bain received two equity awards from Arvinas (ARVN) on June 25, 2025: (1) 16,025 restricted stock units (RSUs) that vest in full on June 25, 2026 or the first board meeting after the next annual stockholder meeting, and (2) stock options to purchase 23,105 shares at an exercise price of $7.80 per share with the same vesting schedule.

How many shares of ARVN does Linda Bain own after the June 2025 grant?

Following the reported transactions, Linda Bain directly owns 26,045 shares of ARVN common stock, plus 23,105 stock options and 16,025 unvested RSUs.

What is the vesting schedule for ARVN's June 2025 director equity grants?

Both the RSUs and stock options granted to Linda Bain will vest in full on the earlier of: (1) June 25, 2026, or (2) the first board of directors meeting held after the next annual meeting of stockholders, subject to continued service with Arvinas.

What is the exercise price of ARVN stock options granted to Linda Bain in June 2025?

The stock options were granted with an exercise price of $7.80 per share and expire on June 24, 2035.

What is Linda Bain's role at ARVN?

According to the Form 4 filing, Linda Bain serves as a Director on Arvinas's Board of Directors.